Teva Rises on Positive Trial Results, Palo Alto Networks Falls Amid Competition Fears
The Tel Aviv Stock Exchange is expected to open with modest gains, mirroring positive trends in Asian markets and futures on Wall Street. However, the dollar's depreciation is expected to temper any significant upward movement. Teva Pharmaceutical Industries is anticipated to rise following positive Phase 2a trial results for its novel antibody, TEV-'408, intended for treating conditions like celiac disease. The trial demonstrated a statistically significant and clinically meaningful reduction in gluten-induced intestinal damage compared to a placebo. While still an early-stage trial with a small patient group, the results bolster Teva's confidence in the drug's potential, as the antibody is also being tested for vitiligo and may have multiple future applications.
Conversely, Palo Alto Networks is projected to decline. Despite reporting a strong financial report, market concerns about increasing competition and the impact of AI tools on pricing are weighing on the stock. The company has seen a significant drop in its market value over the past two days.
Solaris, a renewable energy company, is experiencing a surge in its stock price, significantly exceeding its initial offering price from two and a half years ago. Phoenix Investments maintains a 'Buy' recommendation for Solaris, setting a target price of 163 shekels, reflecting a substantial potential upside. Analysts at Phoenix highlight the company's strategic acquisitions and project connections in Poland, Spain, and other regions as key drivers for future growth. Solaris aims to connect approximately 700 megawatts of capacity by the end of 2026, with an additional 1.4 gigawatt-hours of storage systems in development or acquisition.
In the real estate sector, public developers reported a 36% increase in apartment sales in the second quarter compared to the first, selling a total of 1,571 units. However, this figure remains slightly below the average sales rate over the past 12 quarters. A recent interest rate cut by a quarter percentage point may offer some relief to the housing market by potentially moderating mortgage payments and reducing financing costs for developers, though its standalone impact is considered limited.
